Alternative methods for feline fertility control: Use of melatonin to suppress reproduction

Effectiveness of a Modified Administration Protocol for the Medical Treatment of Feline Pyometra

Pyometra is a common uterine disease of dogs and cats, typical of the luteal phase. Traditionally, ovariohysterectomy was considered the elective treatment for pyometra, but in some cases, such as breeding subjects or patients with a high anesthesiologic risk, medical treatment is preferred. Aglepristone is a progesterone receptor blocker and its use proved to be effective for the medical treatment of pyometra in bitches and queens. The aim of this work is to report the effectiveness, in the feline species, of a modified aglepristone administration protocol. Five intact queens were referred to veterinary care centers for pyometra. Aglepristone (15 mg/kg) was administered at D0, D2, D5, and D8, as described by Contri and collaborators for dogs. An antibiotic treatment (marbofloxacin, 3 mg/kg) was associated, and uterine conditions were checked with regular ultrasonographic exams. The uterus returned to its normal condition 10 days after starting the treatment and no adverse effects were reported. After treatment, three queens had an uneventful pregnancy. Even if the treated group was restricted and homogeneous, the proposed modified protocol proved to be useful and promising for the medical treatment of pyometra in cats; further studies are planned to verify its effectiveness in the long-term prevention of recurrence.

Reproductive Management in Catteries: Optimising health and wellbeing through veterinarian-breeder collaboration

PRACTICAL RELEVANCE

Many veterinarians - even those engaged in small animal reproduction - are uncomfortable with taking care of cat breeders or being in charge of catteries. Likely reasons for this are that feline reproduction is largely under-represented in undergraduate and graduate reproduction teaching, as well as in postgraduate education and science, whereas cat breeders themselves are often well informed and actively share knowledge with other cat breeders via the internet and social media.

CLINICAL CHALLENGES

A variety of problems can exist within a cattery, and collaboration between veterinarian and breeder to solve these is ultimately beneficial for the breeder, for the veterinarian, and for the health and wellbeing of the individual cats and of the cattery as a whole.

AIM

This review presents a comprehensive overview of aspects of cattery management that might negatively impact reproduction, including sanitation, hygiene and infectious disease control. It also discusses monitoring of reproductive performance, breeding recommendations, and the diagnostic and therapeutic approach to some common and specific problems.

EQUIPMENT AND TECHNICAL SKILLS

Reproductive management in the cattery requires no specialised equipment, as such. What it does need is an open mind, in terms of seeing how things are done, an open ear, for listening to the breeder, and the veterinarian's clinical skills in palpation, auscultation and, where required, further examination of the animals. Keeping abreast of the latest information on infectious diseases, disinfection and genetics ensures proper advice is provided.

EVIDENCE BASE

Current knowledge of reproductive management in catteries is summarised in order to apply an evidence-based approach, whenever possible. Notwithstanding, much of the information remains empirical.

Development of the Mata Hari Judas Queen (Felis catus)

Cats (Felis catus) are significant predators of mammals, birds, frogs and reptiles and are implicated in mammal species extinctions in Australia. Current controls fail to eradicate entire populations allowing survivors to re-establish. The use of the Mata Hari Judas (MHJ) technique, i.e., inducing prolonged oestrus using hormone implants, can enhance the eradication of remnant animals and would greatly improve conservation efforts. The hypotheses tested were that hormone implants could induce prolonged oestrus in queens (adult female cats), and that prolonging oestrus would result in sustained attractiveness to toms (adult male cats). Queens (n = 14) were randomly allocated to five treatments including a control and four treatments using hormone implants. Queens were observed daily; alone and during indirect contact with a tom for 30 consecutive days. There were significant increases (p < 0.001) in oestrus duration (19 to 27 days) for entire and ovariohysterectomised queens given Compudose100™ implants (1/8 or 1/4 implant). This study shows that it is possible to induce and prolong oestrus in queens using Compudose100™ implants where these queens are attractive to toms. The MHJ queen is a new tool with the potential to enhance the detection and thus the control of feral cats in remnant populations.

Contraceptive implants used by cat breeders in France: a study of 140 purebred cats

OBJECTIVES

Deslorelin 4.7 mg and melatonin 18 mg subcutaneous implants were studied in purebred male and female cats, via questionnaires sent to French cat breeders, to assess breed, age, duration of the contraceptive effect, fertility after use, changes in behaviour and side effects.

METHODS

Reproductive data were collected in 57 tom cats and 41 queens implanted with deslorelin 4.7 mg, and 42 queens implanted with melatonin 18 mg, for a total of 140 purebred cats, from 38 different catteries, representing 18 breeds.

RESULTS

Using deslorelin (Suprelorin 4.7 mg; Virbac), sexual behaviour in males was inhibited for a mean ± SD of 13.4 ± 3.2 (range 8-21) months in 37/57 cats. Of these, 24/37 mated successfully and produced litters at a mean of 15.5 ± 3.6 (range 9-20) months. Inhibition lasted 11 ± 1.1 (range 9-12; n = 6), 13.2 ± 2.4 (range 12-18; n = 6) and 15 ± 3.5 (range 9-18; n = 6) months in Norwegian Forest Cat, Singapura and Ragdoll males, respectively. In 26/41 females implanted with deslorelin 4.7 mg, oestrus was inhibited for a mean of 16.0 ± 5.7 (8-38) months; 12/26 went on to produce a litter. Of the side effects specific to females: two presented persistent oestrus, leading to the removal of the implant; two developed lactation; one had fibroadenomatosis; and one was sterilised owing to cystic endometrial hyperplasia. Using melatonin (Melovine 18 mg; Ceva), 33/42 females had oestrus inhibited for a mean of 86 ± 50 (range 21-277) days after implantation with a peak return to oestrus in March, and 12/33 had a subsequent litter. No side effects were reported.

CONCLUSIONS AND RELEVANCE

This study is the first to collect a large amount of field data, in 140 purebred male and female cats where a deslorelin 4.7 mg or a melatonin 18 mg implant was used. These field results may allow for more accurate clinical advice and open up new avenues of research.

Preoperative calming effect of melatonin and its influence on propofol dose for anesthesia induction in healthy dogs

OBJECTIVE

To investigate the preoperative calming effect of melatonin and its influence on propofol dose for anesthesia induction in dogs.

STUDY DESIGN

Prospective, randomized, blinded, placebo-controlled clinical study.

ANIMALS

A total of 50 healthy, adult, client-owned dogs scheduled for elective surgery.

METHODS

Dogs were equally divided into treatment group M, which received 5 mg kg^-1 melatonin, and placebo-control group P (sucrose), both administered orally 2 hours prior to induction of anesthesia. Dogs were subjectively characterized and further designated as skeptical (group S; n = 18) or trustful (group T; n = 32). Behavior, calming effect and vital parameters (pulse rate, respiratory rate, blood pressure, rectal temperature) were evaluated before and after treatment. Propofol dose [mg kg^-1 intravenously (IV)] to allow endotracheal intubation and anesthesia induction quality was documented. Data were analyzed using a general linear model and Mann-Whitney U tests.

RESULTS

Dogs in group MS (n = 10) were calmer than those in group PS (n = 8) at 90 minutes after drug administration (p = 0.047). Group MT (n = 15) required less propofol (5.98 ± 0.96 mg kg^-1) than group PT (n = 17; 7.04 ± 1.82 mg kg^-1 IV; p = 0.048) and group MS (9.48 ± 3.22 mg kg^-1 IV; p = 0.007). Group PS required 7.69 ± 2.71 mg kg^-1 IV. Skeptical dogs showed more reactions during induction (p = 0.013). Vital parameters were within physiological ranges before and after treatment.

CONCLUSION AND CLINICAL RELEVANCE

Results showed that melatonin may be used to reduce propofol dose for anesthesia induction in trustful dogs. Skeptical dogs benefitted from the calming properties. Potentially, melatonin could be used to minimize the level of excitement before general anesthesia and to reduce the required propofol dose for induction.

Pyometra in the queen: To spay or not to spay?

PRACTICAL RELEVANCE

Pyometra is a commonly occurring uterine disease in cats that often leads to loss of breeding potential and, in some cases, can be life threatening. An increased incidence of cystic endometrial hyperplasia (CEH) and pyometra is seen with age. Most queens present with uterine lesions after 5-7 years of age (average 7.6 years, range 1-20 years). Clinical signs most commonly occur within 4 weeks of the onset of oestrus in queens that are either mated, spontaneously ovulate or are induced to ovulate (mechanical stimulation or hormone induction). The disease is most often observed in dioestrus.

CLINICAL CHALLENGES

Queens with pyometra often go undiagnosed as there may be few or only very mild clinical signs and laboratory changes. For example, the classic sign of mucopurulent bloody vulvar discharge often goes unnoticed. Abdominal ultrasound is the best tool for diagnosis of pyometra and for monitoring response to therapy.

PATIENT GROUP

Classically, middle-aged/older nulliparous intact queens present with pyometra. However, so-called 'stump pyometra' can occur if ovarian tissue is left behind during ovariectomy or ovariohysterectomy (ovarian remnant syndrome). Queens treated with exogenous steroid hormones such as high doses of megestrol acetate or medroxyprogesterone acetate for oestrus prevention can also develop CEH and pyometra.

EVIDENCE BASE

There has been little published to date on CEH, endometritis and pyometra in the queen and most of the currently available information has been extrapolated from studies carried out in the bitch. The queen and the bitch have very different reproductive physiology; thus, further research and investigation into the precise aetiopathogenesis of these disease processes of the uterus in the queen is warranted.

AUDIENCE

This review is aimed at clinicians working in small animal practice, especially those in countries where surgical sterilisation is not practised as commonly as in the United States, Canada or Australasia, and who will therefore see a greater proportion of intact queens.